LYMPHOPROLIFERATIVE DISORDER
Clinical trials for LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare Virus-Linked cancers: immunotherapy drug shows promise
Disease control Recruiting nowThis study tests whether the immunotherapy drug nivolumab can slow or stop the growth of certain cancers linked to the Epstein-Barr virus. It includes people aged 12 and older whose cancer has not responded to standard treatments. Participants receive nivolumab every two weeks, a…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
New drug combo shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated, slow-growing lymphomas like follicular lymphoma. The goal is to see if the combo can shrink tumors and control the disease. About 49 adults will take part, and researchers will …
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Massive childhood cancer registry aims to unlock better treatments
Knowledge-focused Recruiting nowThis study collects health information and leftover tumor or blood samples from children and young adults with cancer. The goal is to learn more about these diseases and find better ways to treat and care for patients over time. Up to 75,000 people will take part, and no experime…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 03:29 UTC
-
Gene hunt: why CAR-T leaves some patients with low blood counts
Knowledge-focused Recruiting nowThis study aims to understand why some people develop long-lasting low blood cell counts (cytopenia) after CAR-T therapy for multiple myeloma or certain lymphomas. Researchers will analyze participants' genes to find changes that might increase this risk. The goal is to better pr…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC
-
Blood cancer tissue bank aims to fuel future discoveries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from up to 15,000 people with blood cancers or related disorders. The samples are stored in a central bank for researchers to use in future studies. Participants do not receive any treatment as part of this study. The goa…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC